Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence

Breast Cancer Research and Treatment

Volumn 13, Issue 3, 1989, Pages 205-223

  Krieger, Nancy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

abortion; breast neoplasms; race; risk factors; social class; susceptibility to carcinogens

Indexed keywords

CARCINOGEN; ORAL CONTRACEPTIVE AGENT;

BREAST CANCER; BREAST DEVELOPMENT; CANCER INCIDENCE; CANCER RISK; ETHNIC OR RACIAL ASPECTS; FEMALE; HUMAN; HYPOTHESIS; PREGNANCY; PSYCHOLOGICAL ASPECT; THEORETICAL STUDY; ADULT; ARTICLE; BREAST DISEASE; BREAST TUMOR; CAUCASIAN; ENVIRONMENTAL EXPOSURE; NEGRO; RISK FACTOR; SOCIOECONOMICS; SPONTANEOUS ABORTION; UNITED STATES;

ABORTION, SPONTANEOUS; ADULT; BLACKS; BREAST DISEASES; BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; CONTRACEPTIVES, ORAL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MIDDLE AGE; PREGNANCY; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; WHITES;

EID: 0024472958     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF02106571     Document Type: Article

References (168)

1. SEER program: cancer incidence and mortality in the United States, 1973–1981
2. 1986 Annual Cancer Statistics Review
3. Breast cancer epidemiology and risk factors
4. Breast cancer epidemiology
5. The epidemiology of breast cancer
6. Epidemiology of breast cancer: a review
7. Progress in understanding breast cancer: epidemiological and biological interactions
8. Age at first birth and breast cancer risk
9. Age at any birth and breast cancer risk
10. Critical appraisal of the evidence that dietary fat is related to breast cancer risk in humans
11. Dietary fat and the risk of breast cancer
12. A population-based case-control study of diet and breast cancer in Australia
13. Consumption of dairy products and alcohol in a case-control study of breast cancer
14. Alcohol consumption and the risk of breast cancer in women
15. Alcohol consumption and breast cancer
16. Moderate alcohol consumption and the risk of breast cancer
17. Alcohol consumption and breast cancer in the epidemiological follow-up study of the first National Health And Nutrition Examination Survey
18. Cigarette smoking, alcohol consumption and breast cancer risk
19. A meta-analysis of alcohol consumption in relation to risk of breast cancer
20. A critique of the methodology of studies of benign breast disease and breast cancer risk
21. Epidemiology and endocrinology of benign breast disease
22. A prospective study of the development of breast cancer in 16,692 women with benign breast disease
23. Early oral contraceptive use and breast cancer: results of another case-control study
24. A casecontrol study of oral contraceptive use and breast cancer
25. Contraceptive use and breast cancer in young women
26. Oral contraceptive use and early abortion as risk factors for breast cancer in young women
27. An epidemiological study of breast cancer
28. Abortion before first livebirth and risk of breast cancer
29. Risk of breast cancer in relation to reproductive factors in Denmark
30. Risk factors for breast cancer
31. A prospective study of reproductive factors and breast cancer. I. Parity
32. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth
33. Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study
34. Cigarette smoking, relative weight and menopause
35. Use of permanent hair dyes and risk of breast cancer
36. Methylxanthines and breast cancer
37. Reproductive endocrinology and breast cancer in women
38. Long-term effects of a first pregnancy on the secretion of prolactin
39. Interaction of familial and hormonal risk factors for breast cancer
40. Endogenous hormones as a major factor in human cancer
41. ‘Hormonal’ risk factors, ‘breast tissue age’, and the age-incidence of breast cancer
42. Carcinogen testing: Current problems and new approaches
43. Sex hormone levels in serum in relation to the development of breast cancer
44. Endogenous sex hormones, prolactin and breast cancer in premenopausal women
45. Estrogens and breast cancer
46. Estrogen profiles of premenopausal women with breast cancer risk
47. Urine estrogens, frequency of ovulation, and breast cancer risk: a case-control study in premenopausal women
48. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens
49. Plasma hormone profiles of young women at risk for familial breast cancer
50. Elevated levels of prolactin in nulliparous women
51. Plasma hormone levels in different ethnic populations of women
52. Age at menarche, urine estrogens and breast cancer risk
53. Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinoma
54. Prolactin and murine mammary tumorigenesis: a review
55. Clinical importance of risk factors for breast cancer
56. A different perspective on breast cancer risk factors: some implications of nonattributable risk
57. Breast cancer incidence in two populations with different levels of risk for the disease
58. Illness from cancer in the United States
59. Morbidity from cancer in the United States: Part I — Variation in incidence by age, sex, race, marital status, and geographic region
60. Changing ratio of breast cancer incidence rates with age of black females compares with white females in the United States
61. Rising incidence of breast cancer among young women in Washington state
62. Breast cancer in black american women
63. Risk factors for breast cancer in black women
64. Association of breast cancer and cervical cancer incidence with income and education among whites and blacks
65. Nutritional status and dietary patterns of racial minorities
66. Characterizing food usage by demographic variables
67. Food choices and cancer guidelines
68. Projected changes in breast cancer incidence due to a trend toward delayed childbearing
69. The social and economic status of the black population in the United States: An historical view, 1790–1978
70. Rising incidence of breast cancer (letter)
71. Estimates of pregnancies and pregnancy rates for the United States, 1976–85
72. Black demographic trends in the 1980s
73. Mutation selection and the natural history of cancer
74. Differentiation of the mammary gland and susceptibility to carcinogenesis
75. Influence of age and gland topography on cell kinetics of normal human breast tissue
76. The effect of age and menstrual cycle upon proliferative activity of the normal human breast
77. Are cell number and cell proliferation risk factors for cancer?
78. The health of black folk: disease, class and ideology in science
79. Breast development in puberty
80. Development of the mammary gland
81. Function of the normal breast: physiology and endocrine control
82. Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterally
83. An atlas of sub-gross pathology of the human breast with special reference to possible precancerous lesions
84. Cell lineages and interactions in neoplastic expression in the human breast
85. Early pathologic changes in experimental and human breast cancer: facts and comments
86. Two-stage model of carcinogenesis: Epidemiology of breast cancer in females
87. Introduction
88. Breast cancer in atomic bomb survivors
89. Breast cancer in women after repeated fluoroscopic examinations of the chest
90. Changing incidence of breast cancer in Japanese-American women
91. Cancer mortality among the Polish-born in the United States
92. Cancer rates in Hispanic women related to social and economic factors
93. Physiologic, biochemical, and cytological aspects of nipple aspirate fluid
94. Comparison between concentration of trace elements in normal and neoplastic human breast tissue
95. Current concepts: pollutants in breast milk
96. Polychlorinated biphenyls (PCBs) and dichloroethane (DDE) in human milk: effects of maternal factors and previous lactation
97. A study of the epidemiology of breast cancer
98. Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965–67
99. Lactation and reproductive histories of breast cancer patients in Tokyo, Japan
100. Breast cancer in an area of high parity: Sao Paolo, Brazil
101. Reproductive factors in the aetiology of breast cancer
102. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion
103. Noncontraceptive estrogen use and the risk of breast cancer
104. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women
105. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk
106. Breast cancer and oral contraceptives: a review
107. Oral contraceptives and breast cancer in young women
108. Oral contraceptives and breast cancer: a national study
109. Breast cancer risk in relation to type of estrogen contained in oral contraceptives
110. Potential for bias in case-control studies of oral contraceptives and breast cancer
111. Cell proliferation in normal human ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine: effect of menstrual phase, age, and oral contraceptive hormones
112. An epidemiological study on the association between diet and breast cancer
113. Effect of estradiol and the synthetic progestin Promegestone (R5020) on the proliferation of human mammary cells in culture
114. Uptake and concentration of steroid hormones in mammary tissues
115. Importance of mammary gland DNA synthesis in carcinogen-induced mammary tumorigenesis in rats
116. Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylben[a]anthracene
117. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene
118. DNA labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis
119. Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion
120. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence
121. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis
122. Mammary carcinogenesis by 3-methylcholanthracene. II. Inhibitory effect of pregnancy and lactation on tumor induction
123. The role of social class in human pesticide pollution
124. Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem
125. Racial inequality and the probability of occupation-related injury or illness
126. Health status of minorities and low income groups
127. The quality of life for Black Americans twenty years after the civil rights revolution
128. Induced abortions: a worldwide perspective
129. Fallacies of lifestyle cancer theories
130. Adipose tissue: a neglected factor in the aetiology of breast cancer?
131. Ecological correlations and the behavior of individuals
132. A typology of ecologic fallacies
133. The role of ecologic analysis in studies of the etiology of disease: a discussion with reference to large bowel cancer
134. Uses of ecologic analysis in epidemiologic research
135. Two issues concerning the analysis of grouped data
136. The ecological fallacy
137. Incidence of breast feeding in a low socioeconomic group of mothers in the United States: ethnic patterns
138. Promoting breastfeeding in a migrant health center
139. Characteristics of abortion patients in the United States, 1979 and 1980
140. A portrait of American women who obtain abortions
141. Hysterectomy among women of reproductive age, United States, update for 1981–1982
142. Sick individuals and sick populations
143. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976–1980
144. Cigarette smoking and risk of coronary heart disease: epidemiologic clues to pathogenesis — The Framingham Study
145. The treatment of diseases and the war against cancer
146. Progress against cancer?